Diabetes Clinical Trials in Ohio

Showing 341-360 of 627 trials

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

NCT02429258

Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin

Type II Diabetes

AstraZeneca226 participantsStarted May 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Huntington Park, California, United States +23 more locations

COMPLETEDPhase 332 miles

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

NCT02058160

Primary Objective: To demonstrate the superiority of the insulin glargine/lixisenatide fixed ratio combination (FRC) to insulin glargine in glycated hemoglobin (HbA1c) change from baseline to Week 30. Secondary Objective: To compare the overall efficacy and safety of insulin glargine/lixisenatide FRC to insulin glargine (with or without metformin) over a 30 week treatment period in participants with type 2 diabetes.

Type 2 Diabetes

Sanofi736 participantsStarted Jan 2014

Birmingham, Alabama, United States • Sun City, Arizona, United States • Tempe, Arizona, United States +233 more locations

PreviousPage 18 of 32Next

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Diabetes Trials in Other Cities

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Extended Follow-Up After Islet Transplantation in T1D

OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits

Improving Outcomes in Underserved Women With GDM

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Healthy.io Method Comparison & User Performance Study

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Other Conditions in Ohio